3-tyr-octreotide has been researched along with Neoplasm Metastasis in 3 studies
*Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abs, R; Beckers, A; Foidart-Willems, J; Meurisse, M; Pham, VT | 1 |
| Bardies, M; Baulieu, J; Besnard, JC; Chatal, J; Chauvet, AF; Faurous, P; Guilloteau, D; Lecloirec, J; Malhaire, J; Pourcelot, L; Resche, I; Sassolas, G; Thomas, E | 1 |
| Foekens, JA; Klijn, JG; Laissue, J; Lamberts, SW; Reubi, JC; Waser, B | 1 |
1 review(s) available for 3-tyr-octreotide and Neoplasm Metastasis
| Article | Year |
|---|---|
[Scintigraphic localization of neuroendocrine tumors and their metastases using a somatostatin analog [111In-DTPA-d-phe1] octreotide].
Topics: Aged; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Octreotide; Radionuclide Imaging | 1993 |
2 other study(ies) available for 3-tyr-octreotide and Neoplasm Metastasis
| Article | Year |
|---|---|
[131I]-TYR3-octreotide: clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors.
Topics: Adult; Carcinoid Tumor; Humans; Isotope Labeling; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Paraganglioma; Radiometry; Radiopharmaceuticals; Treatment Outcome | 2000 |
Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors.
Topics: Amino Acid Sequence; Autoradiography; Breast Neoplasms; ErbB Receptors; False Negative Reactions; Humans; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Octreotide; Receptors, Neurotransmitter; Receptors, Somatostatin | 1990 |